Skip to main navigation Skip to search Skip to main content

In vitro metabolism studies of new adenosine A 2A receptor antagonists

  • G. Marucci
  • , S. Finaurini
  • , M. Buccioni
  • , C. Lammi
  • , M. Kandhavelu
  • , R. Volpini
  • , M. Ricciutelli
  • , P. Angeli
  • , J.N.M. Commandeur
  • , G. Cristalli

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Evidence, obtained in rodent and primate models of Parkinson's disease (PD) and in preliminary clinical trials, indicates that adenosine A
    Original languageEnglish
    Pages (from-to)301-7
    JournalDrug Metab Letters
    Volume2
    Issue number4
    DOIs
    Publication statusPublished - 2008

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'In vitro metabolism studies of new adenosine A 2A receptor antagonists'. Together they form a unique fingerprint.

    Cite this